On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Asphalion SL's own share of each project, not the project's full budget.
- Horizon 2020€3.1M · 13 projects
- Horizon Europe€2.7M · 15 projects
- FP7 (2007 to 2013)€160k · 1 project
Projects
29 EU-funded projects, newest first. Each links to the official record.
- DYNAMISAssociated partner
IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions
Horizon Europe · 2026–2030 · Project on CORDIS ↗
- VIVIDPartner
Clinical Validation of In Vivo Imaging for Detecting Immune Dynamics
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€128ktheir share - GreenNanoBonePartner
Sustainable 4D hydrogels functionalised with plant-based nanoparticles for bone regeneration in cancer patients
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€197ktheir share - HYDROHEALPartner
Multi-functional hydrogels for promoting bone fracture healing through local induced release of pharmaceutical agents and gradual matrix replacement by the regenerating bone
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€196ktheir share - MEDiCSPartner
Anticancer approach based on the Metabolic Disruption of Cancer Stem Cells with high effectivity across a wide range of solid tumours
Horizon Europe · 2025–2028 · Project on CORDIS ↗
€153ktheir share - KeratOPrinterPartner
Advanced 4D Printing Technologies in Corneal Regeneration: A Pathway to Restored Vision
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€267ktheir share - IMMUTOLPartner
ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€198ktheir share - PragmaTILPartner
Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€168ktheir share - FORCE REPAIRPartner
smart and multiFunctional 3D printable prO-Regenerative biologiCal matrix modulating mEchanotRansduction as advancEd theraPy to treAt skIn chRonic wounds
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€176ktheir share - NABIHEALPartner
ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€134ktheir share - METHYLOMICPartner
DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€239ktheir share - EChiLiBRiSTPartner
Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€128ktheir share - ETERNALPartner
Boosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€152ktheir share - SINPAINPartner
A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to treat knee osteoarthritis
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€204ktheir share - RBDCOVPartner
RBD Dimer recombinant protein vaccine against SARSCoV2
Horizon Europe · 2021–2025 · Project on CORDIS ↗
€350ktheir share - UroPrintPartner
Urinary bladder bioprinting for fully autologous transplantation
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€75ktheir share - Tumor-LN-oCPartner
Tumor and Lymph Node on Chip for cancer studies
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€237ktheir share - SPIOMET4HEALTHPartner
PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY
Horizon 2020 · 2021–2026 · Project on CORDIS ↗
€223ktheir share - IN2SIGHTPartner
AN IN VIVO BIOENGINEERED CHIP AS A SMART INTRAVITAL MULTIPHOTON IMAGING WINDOW FOR NEW VALIDATION PROTOCOLS OF BIOMATERIALS
Horizon 2020 · 2021–2025 · Project on CORDIS ↗
€265ktheir share - VASCOVIDPartner
PORTABLE PLATFORM FOR THE ASSESSMENT OF MICROVASCULAR HEALTH IN COVID-19 PATIENTS AT THE INTENSIVE CARE
Horizon 2020 · 2020–2023 · Project on CORDIS ↗
€182ktheir share - ARDATPartner
Accelerating Research & Development for Advanced Therapies
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€353ktheir share - MISTRALPartner
Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€141ktheir share - €318ktheir share
- CardioReGenixPartner
CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€310ktheir share - nTRACKPartner
Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€306ktheir share - HIVACARPartner
Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€175ktheir share - MYOCUREPartner
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€275ktheir share - ELASTISLETPartner
Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
€223ktheir share - IHIVARNAPartner
Therapeutic TriMix / mRNA based Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral Therapy
FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗
€160ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Mybiotech GmbHGermany · 6 shared projects
- Eurice European Research and Project Office GmbHGermany · 5 shared projects
- Vrije Universiteit BrusselBelgium · 4 shared projects
- Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 4 shared projects
- Fundacio Privada Institut de Recerca Sobre Immunopatologies-Caixa, IrsicaixaSpain · 4 shared projects
- Hospital Clinic de BarcelonaSpain · 4 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 3 shared projects
- Aarhus UniversitetDenmark · 3 shared projects
- Stichting Amsterdam UmcNetherlands · 3 shared projects
- The University of LiverpoolUnited Kingdom · 3 shared projects
- Universidade de AveiroPortugal · 3 shared projects
- Zabala Innovation Consulting SASpain · 3 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 2 shared projects
- Helsingin YliopistoFinland · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- HIV
- antibiotic resistance
- artificial bone
- autoimmune diseases
- biomaterials
- bioreactors
- biosensors
- breast cancer
- cardiology
- cells technologies
- coronaviruses
- critical care medicine
- deep learning
Asphalion SL is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
